| Product Name |
MF |
CAS |
Details |
| Methyl 7-(2-Methoxyethyl)-1,3-diMethyl-2,4-dioxo-2,3,4,7-tetrahydro-1H-pyrrolo[2,3-d]pyriMidine-6-carboxylate, 96% |
C13H17N3O5 |
1086386-34-6 |
|
| 2-BroMo-N-(3-fluorobenzyl)aniline, 97% |
C13H11BrFN |
1020929-55-8 |
|
| 3,4-Difluoro-N-(4-fluorobenzyl)aniline, 97% |
C13H10F3N |
1019621-42-1 |
|
| 4-Chloro-N-(3-fluorobenzyl)aniline, 97% |
C13H11ClFN |
1019518-52-5 |
|
| 3-Chloro-N-(3-fluorobenzyl)aniline, 97% |
C13H11ClFN |
1019612-70-4 |
|
| 3-Fluoro-N-(4-fluorobenzyl)aniline, 97% |
C13H11F2N |
1019613-18-3 |
|
| 2-BroMo-4-fluoro-N-(2-fluorobenzyl)aniline, 97% |
C13H10BrF2N |
1038976-20-3 |
|
| N-(4-Fluorobenzyl)-4-iodoaniline, 97% |
C13H11FIN |
1040018-16-3 |
|
| 3,5-Dichloro-N-(3-fluorobenzyl)aniline, 97% |
C13H10Cl2FN |
1040010-63-6 |
|
| 2,6-Difluoro-N-(3-fluorobenzyl)aniline, 97% |
C13H10F3N |
1039839-41-2 |
|
| 2,4-DibroMo-N-(2-fluorobenzyl)aniline, 97% |
C13H10Br2FN |
1152619-64-1 |
|
| 4-Ethyl-N-(2-fluorobenzyl)aniline, 97% |
C15H16FN |
1019570-78-5 |
|
| 2-Cyclopropyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)pyriMidine |
C13H19BN2O2 |
1375301-91-9 |
|
| 4-Fluoro-1H-indazole-7-carbonitrile |
C8H4FN3 |
1408058-17-2 |
|
| N-[(1S,2S)-2-Aminocyclohexyl]-N'-[3,5-bis(trifluoromethyl)phenyl]thiourea |
C15H17F6N3S |
1027476-96-5 |
|
| H-ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA-OH |
C180H287N57O48 |
112540-82-6 |
|
| 2-PropanaMine, N-(2-chloroethyl)-, hydrochloride |
C5H13Cl2N |
6306-61-2 |
|
| 4-MorpholinecarboxaMide, N-(2-aMinoethyl)- |
C7H15N3O2 |
69630-16-6 |
|
| Benzenesulfonic acid, 3-hydroxy-, MonosodiuM salt |
C6H5NaO4S |
14278-60-5 |
|
| 3'-Hydroxypropiophenone |
C9H10O2 |
13103-80-5 |
|
| 3-(2-Cyanopropan-2-yl)benzoic acid |
C11H11NO2 |
872091-00-4 |
|
| ethyl 4,5-diMethyl-1H-pyrazole-3-carboxylate |
C8H12N2O2 |
15803-27-7 |
|
| 5-Fluoro-7-Methyl indole |
C9H8FN |
1082041-52-8 |
|
| (E)-Ethyl 3-aMino-4,4,4-trifluorocrotonate |
C6H8F3NO2 |
498583-09-8 |
|
| 4-BroMo-1-Methyl-1H-iMidazole-2-carboxylic acid ethyl ester |
C7H9BrN2O2 |
1260672-33-0 |
|
| 4-BroMo-1-Methyl-1H-iMidazole-2-carboxylic acid ethyl ester |
C7H9BrN2O2 |
1260672-33-0 |
|
| 1-(1-(3,4-dichlorophenyl)cyclobutyl)-N,N,3-triMethylbutan-1-aMine |
C17H25Cl2N |
766462-77-5 |
|
| 3,4-DiMethoxy-N-(3-fluorobenzyl)aniline |
C15H16FNO2 |
1019488-75-5 |
|
| 1-(2-Chloro-4-pyridylcarbonyl)-4-Methylpiperidine, 95% |
C12H15ClN2O |
1019405-64-1 |
|
| 4-(1,1-Difluoroethyl)benzoic acid |
C9H8F2O2 |
55805-14-6 |
|
| 3H-Pyrazol-3-one, 2,4-dihydro-4,4-bis(5-hydroxy-3-Methyl- 1-phenyl-1H-pyrazol-4-yl)-5-Methyl-2-phenyl- |
C30H26N6O3 |
124009-63-8 |
|
| 2-chloro-4-[2-[2,5-dimethyl-1-[4-(trifluoromethoxy)phenyl]imidazol-4-yl]ethynyl]pyridine |
C19H13ClF3N3O |
871362-31-1 |
|
| 1H-Pyrrolo[2,3-b]pyridine-2-carboxylic acid, 5-chloro-3-iodo-, ethyl ester |
C16H24N2O |
1132746-05-4 |
|
| Dimethyl isophthalate |
C10H10O4 |
1459-93-4 |
|
| 4,6-Dichlorocinnoline |
C8H4Cl2N2 |
68211-13-2 |
|
| (1S,3aR,6aS)-2-[(2S)-2-[[(2S)-2-Cyclohexyl-2-[(2-pyrazinylcarbonyl)amino]acetyl]amino]-3,3-dimethyl-1-oxobutyl]octahydrocyclopenta[c]pyrrole-1-carboxylic acid tert-butyl ester |
C31H47N5O5 |
926276-19-9 |
|
| 2,6-Diethoxypyridine |
C9H13NO2 |
13472-57-6 |
|
| 4-Boc-2-(broMoMethyl)Morpholine |
C10H18BrNO3 |
765914-78-1 |
|
| D-Gluconic acid, δ-lactone, 2,3,4,6-tetraacetate |
C14H18O10 |
61259-48-1 |
|
| ethyl1-(4-chlorophenyl)cyclopentanecarboxylate |
C14H17ClO2 |
278791-36-9 |
|
| 5-Heptenoic acid, 7-[3-[[(1,1-diMethylethyl)diMethylsilyl]oxy]-5-oxo-1-cyclopenten-1-yl]-, Methyl ester, (Z)- (9CI) |
C19H32O4Si |
132619-70-6 |
|
| 1-p-tolylhexan-1-one |
C13H18O |
1669-33-6 |
|
| 1-p-tolylhexan-1-one |
C13H18O |
1669-33-6 |
|
| 5-broMo-3-ethyl-1H-pyrazolo[3,4-b]pyridine |
C8H8BrN3 |
1449117-35-4 |
|
| 4-Methoxy-D-tryptophan |
C12H14N2O3 |
1094396-87-8 |
|
| TAK-441 |
C28H31F3N4O6 |
1186231-83-3 |
|
| 6-aMino-3,4-dihydro-2H-chroMen-2-one |
C9H9NO2 |
103441-69-6 |
|
| DEC-POC PMPA |
C18H28N5O10P |
1422284-16-9 |
|
| GDC-0623 |
C16H14FIN4O3 |
1168091-68-6 |
|
| 4-Fluoro-6-iodo-1H-indazole |
C7H4FIN2 |
887568-03-8 |
|
| 4-Chloro-5-iodo-nicotinonitrile |
C6H2ClIN2 |
959972-34-0 |
|
| N-(9R)-Cinchonan-9-yl-N'-[(2R)-2-pyrrolidinylmethyl]thiourea |
C25H33N5S |
1222966-44-0 |
|
| N-METHOXY-N-METHYLISONICOTINAMIDE |
C8H10N2O2 |
100377-32-0 |
|
| H-PHG-OTBU HCL |
C12H17NO2.ClH |
161879-12-5 |
|
| Ethyl 2-(3,4-dihydroquinolin-1(2H)-yl)acetate |
C13H17NO2 |
142978-20-9 |
|
| (2-METHYLALLYLOXY)TRIMETHYLSILANE |
C7H16OSi |
25195-85-1 |
|
| 5-Chloro-4-nitro-1-propyl-1H-pyrazole |
C6H8ClN3O2 |
1429309-41-0 |
|
| Moxifloxacin Impurity 4 |
C21H24FN3O4.ClH |
1394029-14-1 |
|
| 5-BroMo-4-MethoxypyriMidine |
C5H5BrN2O |
4319-85-1 |
|
| 1-(5-Hydroxypyrazin-2-yl)ethanone |
C6H6N2O2 |
1159813-33-8 |
|
| (3-Bromo-4-methylphenoxy)(tert-butyl)dimethylsilane |
C13H21BrOSi |
164513-48-8 |
|
| BVT-14225 |
C16H20ClN3O3S2 |
376638-65-2 |
|
| 4-HYDROXY-2-(TRIFLUOROMETHYL)BENZOIC ACID |
C8H5F3O3 |
320-32-1 |
|
| 2-Methyl-6-(4,4,5,5-tetraMethyl-[1,3,2]dioxaborolan-2-yl)-2,3-dihydro-isoindol-1-one |
C15H20BNO3 |
1313399-38-0 |
|
| 2-HYDROXYPROPYLTRIMETHYLAMMONIUMFORMATE |
C7H17NO3 |
62314-25-4 |
|
| 1-broMo-4-iodobutane |
C4H8BrI |
89044-65-5 |
|
| (1S,2S,3R,5S)-3-(7-((1S,2R)-2-(3,4-difluorophenyl)cyclopropylaMino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
C23H28F2N6O4S |
2096989-56-7 |
|
| 5-AMino-2-(Boc-aMinoMethyl)pyridine |
C11H17N3O2 |
1780934-03-3 |
|
| 5-AMino-2-(Boc-aMinoMethyl)pyridine |
C11H17N3O2 |
1780934-03-3 |
|
| N-Boc-(S)-2-(MethylaMino)butyric acid |
C10H19NO4 |
101759-74-4 |
|
| N-FMoc-N'-Boc-D-histidine |
C26H27N3O6 |
159631-28-4 |
|
| nonyl(phenyl)sulfane |
C15H24S |
56358-04-4 |
|
| 3-benzyl-[1,2]oxathiolane 2,2-dioxide |
C10H12O3S |
75732-43-3 |
|
| 2-(2-Methoxyethyl)pyrrolidine |
C7H15NO |
933746-73-7 |
|
| 1H-Pyrazolo[3,4-c]pyridine, 7-chloro-1-methyl- |
C7H6ClN3 |
957760-15-5 |
|
| METHOXY-TRIS(PENTAFLUOROPHENYL)SILANE |
C19H3F15OSi |
223668-78-8 |
|
| 4-BroMo-3-Methyl-2-nitroaniline |
C7H7BrN2O2 |
854624-54-7 |
|
| 3,6-DibroMopyrazine-2-carbonitrile |
C5HBr2N3 |
1351238-11-3 |
|
| 1,2-dibromo-4-methyl-5-nitrobenzene |
C7H5Br2NO2 |
101580-70-5 |
|
| 3,3,3-Trifluoro-2-Methylpropanoic acid |
C4H5F3O2 |
381-97-5 |
|
| ONO 7643 FuMarate |
C35H46N6O7 |
339539-92-3 |
|
| (3aR,6aS)-benzyl 5-oxohexahydrocyclopenta[c]pyrrole-2(1H)-carboxylate |
C15H17NO3 |
1217315-21-3 |
|
| LY 2801653 dihydrochloride |
C30H23ClF2N6O3 |
1206801-37-7 |
|
| 1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-β-oxo- |
C16H20N6O |
344418-92-4 |
|
| X-376 |
C25H25Cl2FN6O3 |
1365267-27-1 |
|
| 2-(6-chloroimidazo[1,2-a]pyridin-2-yl)acetic acid |
C9H7ClN2O2 |
59128-13-1 |
|
| 2-Chloro-6-Hydroxyisonicotinic Acid |
C6H4ClNO3 |
6313-51-5 |
|
| Budesonide iMpurity |
C24H32O6 |
192057-49-1 |
|
| Fluticasone IMpurity |
C27H30F2O6S |
397864-58-3 |
|
| 4-[4-(N-(3-chloro-(2R)-2-hydroxy-1-propyl)aMino)phenyl]Morpholin-3-one |
C13H17ClN2O3 |
1252018-10-2 |
|
| tert-butyl 4-(4-broMo-3-(trifluoroMethyl)-1H-pyrazol-1-yl)piperidine-1-carboxylate |
C14H19BrF3N3O2 |
1449117-75-2 |
|
| (S)-(-)-WARFARIN |
C19H16O4 |
5543-57-7 |
|
| trans-1-(Boc-aMino)-4-ethynylcyclohexane |
C13H21NO2 |
947141-86-8 |
|
| [(S)-P-Phos RuCl (p-cyMene)]Cl |
C48H46Cl2N2O4P2Ru |
1034001-47-2 |
|
| 2-(4-BroMo-2-thienyl)benziMidazole, 95% |
C11H7BrN2S |
1025843-75-7 |
|
| 4-Chloro-N-(2-Methylbenzyl)benzaMide |
C15H14ClNO |
125552-99-0 |
|
| Methyl trans-3-(benzyloxycarbonylaMino)cyclohexanecarboxylate, 97% |
C16H21NO4 |
1035325-22-4 |
|
| N-(3,4-DiMethylphenyl)-3-nitrobenzaMide, 97% |
C15H14N2O3 |
102631-07-2 |
|
| PotassiuM 2-Methoxypyridine-5-trifluoroborate |
C6H6BF3NO.K |
1144573-61-4 |
|
| trans-1-(Boc-aMino)-4-(4-Methyl-1-piperazinyl)cyclohexane |
C16H31N3O2 |
1119283-74-7 |
|
